| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.26 | 2e-06 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |